Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Industry Trends and Market Forecast 2026–2030
Uncover key drivers, emerging technologies, and competitive movements shaping the artificial intelligence (ai)-enhanced remote patient intravenous (iv) monitoring market from 2026–2035 with trusted insights from The Business Research Company
What size range is anticipated for the Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market from 2026 to 2030?
The artificial intelligence (AI)-enhanced remote patient intravenous (iv) monitoring market size has experienced substantial expansion in recent years. This market is projected to increase from $1.69 billion in 2025 to $2.05 billion in 2026, reflecting a compound annual growth rate (CAGR) of 21.6%. The historical growth of this market can be ascribed to factors such as the increasing application of intravenous therapies in clinical settings, a rising occurrence of infusion-related complications, the expansion of hospital patient monitoring systems, the growing embrace of smart infusion devices, and a heightened emphasis on medication safety protocols.
The artificial intelligence (AI)-enhanced remote patient intravenous (iv) monitoring market size is anticipated to experience substantial expansion over the next few years. It is projected to reach $4.45 billion by 2030, growing at a compound annual growth rate (CAGR) of 21.3%. This projected growth is driven by the increasing adoption of AI-enabled infusion monitoring, a rising demand for home-based IV therapy solutions, the expansion of predictive patient safety analytics, the growing integration of connected infusion systems, and an increasing emphasis on remote clinical monitoring. Noteworthy trends during the forecast period involve the increasing adoption of real-time IV flow analytics, a rising use of AI-based infusion error detection, the growing integration of smart infusion sensors, the expansion of remote IV therapy management, and an enhanced focus on patient safety and compliance.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28921&type=smp
What Drivers Are Affecting Demand In The Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market?
The increasing availability of telehealth services is anticipated to fuel the expansion of the Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market in the future. Telehealth involves delivering healthcare remotely through digital communication tools for consultations, monitoring, and treatment. Its growth stems from regulatory adjustments and reimbursement policies introduced during the COVID-19 pandemic, which made virtual healthcare more accessible and economically feasible for both healthcare providers and patients. This AI-enhanced remote patient intravenous (IV) monitoring technology assists telehealth by offering real-time, distant tracking of patients’ IV treatments, automatically identifying potential complications, giving valuable information to healthcare professionals, and integrating smoothly with virtual care systems. This ensures quick actions, better patient safety, and more effective management of care at home and for outpatients. For example, in April 2023, FAIR Health Inc., a US-based non-profit organization, reported that national telehealth usage grew by 7.3% in 2023, moving from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Consequently, the increased use of telehealth services is a key factor boosting the expansion of the Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market.
Which Segment Groups Are Influencing The Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market?
The artificial intelligence (AI)-enhanced remote patient intravenous (iv) monitoring market covered in this report is segmented –
1) By Component: Hardware, Software, Services
2) By Deployment Mode: On-Premises, Cloud-Based
3) By Application: Hospitals, Clinics, Homecare Settings, Ambulatory Surgical Centers, Other Applications
4) By End-User: Healthcare Providers, Patients
Subsegments:
1) By Hardware: Patient Monitoring Devices, Sensors And Infusion Pumps, Communication Devices, Data Storage Systems
2) By Software: Predictive Analytics Software, Clinical Decision Support Software, Remote Monitoring Software, Data Management Software
3) By Services: Implementation And Integration Services, Maintenance And Support Services, Training And Education Services, Remote Monitoring Services
Who Are The Top-Performing Companies In The Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market In Recent Years?
Major companies operating in the artificial intelligence (AI)-enhanced remote patient intravenous (iv) monitoring market are Medtronic plc, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Epic Systems Corporation, ICU Medical Inc., InfuSystem Holdings Inc., AlayaCare Inc., Huma Therapeutics Ltd., Health Recovery Solutions Inc., Arcomed AG, VitalConnect Inc., Cloud DX Inc., Empatica S.r.l., AccuHealth Inc., Serum Tracker Inc.
Access The Complete Report For Deeper Market Insights:
Which Region Currently Holds The Largest Share Of The Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market?
North America was the largest region in the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-enhanced remote patient intravenous (iv) monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=28921&type=smp
Browse Through More Reports Similar to the Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market 2026, By The Business Research Company
Artificial Intelligence In Healthcare Market Report 2026
Ai In Medical Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/ai-in-medical-devices-global-market-report
Artificial Intelligence Or Machine Learning Ai Or Ml Medical Device Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
